nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—ORM1—Abiraterone—prostate cancer	0.211	0.668	CbGbCtD
Amoxapine—CYP2D6—Bicalutamide—prostate cancer	0.0529	0.167	CbGbCtD
Amoxapine—CYP2D6—Abiraterone—prostate cancer	0.0438	0.139	CbGbCtD
Amoxapine—HTR7—vas deferens—prostate cancer	0.0193	0.314	CbGeAlD
Amoxapine—CYP2D6—Doxorubicin—prostate cancer	0.0081	0.0256	CbGbCtD
Amoxapine—HRH4—bone marrow—prostate cancer	0.00416	0.0677	CbGeAlD
Amoxapine—HTR2A—urine—prostate cancer	0.00299	0.0487	CbGeAlD
Amoxapine—CYP2D6—urine—prostate cancer	0.00273	0.0444	CbGeAlD
Amoxapine—DRD4—testis—prostate cancer	0.00241	0.0393	CbGeAlD
Amoxapine—ORM1—prostate gland—prostate cancer	0.00238	0.0388	CbGeAlD
Amoxapine—Lorazepam—UGT2B15—prostate cancer	0.00211	0.225	CrCbGaD
Amoxapine—CHRM1—prostate gland—prostate cancer	0.00202	0.0329	CbGeAlD
Amoxapine—ADRA1A—prostate gland—prostate cancer	0.00166	0.0271	CbGeAlD
Amoxapine—HRH1—prostate gland—prostate cancer	0.00129	0.0209	CbGeAlD
Amoxapine—HTR7—epithelium—prostate cancer	0.00127	0.0206	CbGeAlD
Amoxapine—ADRA2A—prostate gland—prostate cancer	0.00126	0.0206	CbGeAlD
Amoxapine—HTR1A—renal system—prostate cancer	0.00123	0.02	CbGeAlD
Amoxapine—ORM1—bone marrow—prostate cancer	0.00123	0.02	CbGeAlD
Amoxapine—ADRA1A—epithelium—prostate cancer	0.00122	0.0199	CbGeAlD
Amoxapine—HTR7—renal system—prostate cancer	0.00117	0.0191	CbGeAlD
Amoxapine—ADRA1A—renal system—prostate cancer	0.00113	0.0184	CbGeAlD
Amoxapine—Oxazepam—UGT2B15—prostate cancer	0.00111	0.118	CrCbGaD
Amoxapine—ADRA2A—seminal vesicle—prostate cancer	0.00107	0.0174	CbGeAlD
Amoxapine—SLC6A3—testis—prostate cancer	0.000976	0.0159	CbGeAlD
Amoxapine—Oxazepam—CYP3A43—prostate cancer	0.00096	0.102	CrCbGaD
Amoxapine—HRH1—epithelium—prostate cancer	0.000945	0.0154	CbGeAlD
Amoxapine—HRH1—urethra—prostate cancer	0.000861	0.014	CbGeAlD
Amoxapine—ADRA2A—urethra—prostate cancer	0.000846	0.0138	CbGeAlD
Amoxapine—HTR2A—epithelium—prostate cancer	0.00079	0.0129	CbGeAlD
Amoxapine—SLC6A2—testis—prostate cancer	0.000788	0.0128	CbGeAlD
Amoxapine—ORM1—lymph node—prostate cancer	0.000761	0.0124	CbGeAlD
Amoxapine—HTR7—testis—prostate cancer	0.000759	0.0124	CbGeAlD
Amoxapine—HTR2A—renal system—prostate cancer	0.000732	0.0119	CbGeAlD
Amoxapine—DRD2—testis—prostate cancer	0.000718	0.0117	CbGeAlD
Amoxapine—Desloratadine—CYP2C19—prostate cancer	0.000709	0.0755	CrCbGaD
Amoxapine—CYP2D6—renal system—prostate cancer	0.000667	0.0109	CbGeAlD
Amoxapine—HTR2B—lymph node—prostate cancer	0.000643	0.0105	CbGeAlD
Amoxapine—SLC6A2—lymph node—prostate cancer	0.000571	0.00929	CbGeAlD
Amoxapine—HRH1—testis—prostate cancer	0.000567	0.00923	CbGeAlD
Amoxapine—ADRA2A—testis—prostate cancer	0.000557	0.00906	CbGeAlD
Amoxapine—Asenapine—ADRB2—prostate cancer	0.000531	0.0565	CrCbGaD
Amoxapine—HTR2A—testis—prostate cancer	0.000473	0.00771	CbGeAlD
Amoxapine—CYP2D6—testis—prostate cancer	0.000431	0.00702	CbGeAlD
Amoxapine—HRH1—lymph node—prostate cancer	0.000411	0.00669	CbGeAlD
Amoxapine—ADRA2A—lymph node—prostate cancer	0.000404	0.00657	CbGeAlD
Amoxapine—Diazepam—CYP2C18—prostate cancer	0.0003	0.0319	CrCbGaD
Amoxapine—Asenapine—CYP3A4—prostate cancer	0.000291	0.0309	CrCbGaD
Amoxapine—Olanzapine—CYP2C19—prostate cancer	0.000254	0.0271	CrCbGaD
Amoxapine—Clozapine—CYP1B1—prostate cancer	0.000245	0.026	CrCbGaD
Amoxapine—Oxazepam—CYP3A5—prostate cancer	0.000241	0.0256	CrCbGaD
Amoxapine—Quetiapine—CYP3A5—prostate cancer	0.000227	0.0241	CrCbGaD
Amoxapine—Eosinophilia—Epirubicin—prostate cancer	0.000216	0.000564	CcSEcCtD
Amoxapine—Flatulence—Capecitabine—prostate cancer	0.000215	0.000562	CcSEcCtD
Amoxapine—Nausea—Goserelin—prostate cancer	0.000214	0.000559	CcSEcCtD
Amoxapine—Pancreatitis—Epirubicin—prostate cancer	0.000214	0.000559	CcSEcCtD
Amoxapine—Dysgeusia—Capecitabine—prostate cancer	0.000214	0.000558	CcSEcCtD
Amoxapine—Nausea—Conjugated Estrogens—prostate cancer	0.000212	0.000554	CcSEcCtD
Amoxapine—Urticaria—Mitoxantrone—prostate cancer	0.000211	0.000552	CcSEcCtD
Amoxapine—Anorexia—Etoposide—prostate cancer	0.000211	0.000551	CcSEcCtD
Amoxapine—Body temperature increased—Mitoxantrone—prostate cancer	0.00021	0.00055	CcSEcCtD
Amoxapine—Abdominal pain—Mitoxantrone—prostate cancer	0.00021	0.00055	CcSEcCtD
Amoxapine—Hypotension—Etoposide—prostate cancer	0.000207	0.00054	CcSEcCtD
Amoxapine—Vision blurred—Capecitabine—prostate cancer	0.000206	0.000537	CcSEcCtD
Amoxapine—Asthenia—Estradiol—prostate cancer	0.000205	0.000535	CcSEcCtD
Amoxapine—Tremor—Capecitabine—prostate cancer	0.000204	0.000534	CcSEcCtD
Amoxapine—Syncope—Docetaxel—prostate cancer	0.000202	0.000528	CcSEcCtD
Amoxapine—Pruritus—Estradiol—prostate cancer	0.000202	0.000528	CcSEcCtD
Amoxapine—Leukopenia—Docetaxel—prostate cancer	0.000202	0.000527	CcSEcCtD
Amoxapine—Pollakiuria—Epirubicin—prostate cancer	0.000201	0.000527	CcSEcCtD
Amoxapine—Eosinophilia—Doxorubicin—prostate cancer	0.0002	0.000522	CcSEcCtD
Amoxapine—Palpitations—Docetaxel—prostate cancer	0.000199	0.00052	CcSEcCtD
Amoxapine—Paraesthesia—Etoposide—prostate cancer	0.000199	0.000519	CcSEcCtD
Amoxapine—Weight increased—Epirubicin—prostate cancer	0.000198	0.000519	CcSEcCtD
Amoxapine—Loss of consciousness—Docetaxel—prostate cancer	0.000198	0.000518	CcSEcCtD
Amoxapine—Pancreatitis—Doxorubicin—prostate cancer	0.000198	0.000517	CcSEcCtD
Amoxapine—Diazepam—CYP3A5—prostate cancer	0.000197	0.021	CrCbGaD
Amoxapine—Alopecia—Prednisone—prostate cancer	0.000197	0.000516	CcSEcCtD
Amoxapine—Somnolence—Etoposide—prostate cancer	0.000197	0.000514	CcSEcCtD
Amoxapine—Syncope—Capecitabine—prostate cancer	0.000196	0.000511	CcSEcCtD
Amoxapine—Diarrhoea—Estradiol—prostate cancer	0.000195	0.000511	CcSEcCtD
Amoxapine—Leukopenia—Capecitabine—prostate cancer	0.000195	0.00051	CcSEcCtD
Amoxapine—Convulsion—Docetaxel—prostate cancer	0.000195	0.00051	CcSEcCtD
Amoxapine—Hypertension—Docetaxel—prostate cancer	0.000194	0.000508	CcSEcCtD
Amoxapine—Drowsiness—Epirubicin—prostate cancer	0.000194	0.000508	CcSEcCtD
Amoxapine—Palpitations—Capecitabine—prostate cancer	0.000193	0.000504	CcSEcCtD
Amoxapine—Decreased appetite—Etoposide—prostate cancer	0.000192	0.000503	CcSEcCtD
Amoxapine—Loss of consciousness—Capecitabine—prostate cancer	0.000192	0.000501	CcSEcCtD
Amoxapine—Asthenia—Mitoxantrone—prostate cancer	0.000191	0.000499	CcSEcCtD
Amoxapine—Fatigue—Etoposide—prostate cancer	0.000191	0.000499	CcSEcCtD
Amoxapine—Stomatitis—Epirubicin—prostate cancer	0.00019	0.000495	CcSEcCtD
Amoxapine—Jaundice—Epirubicin—prostate cancer	0.00019	0.000495	CcSEcCtD
Amoxapine—Constipation—Etoposide—prostate cancer	0.000189	0.000495	CcSEcCtD
Amoxapine—Dizziness—Estradiol—prostate cancer	0.000189	0.000493	CcSEcCtD
Amoxapine—Clozapine—CYP2A6—prostate cancer	0.000189	0.0201	CrCbGaD
Amoxapine—Hypertension—Capecitabine—prostate cancer	0.000188	0.000492	CcSEcCtD
Amoxapine—Dry mouth—Docetaxel—prostate cancer	0.000188	0.00049	CcSEcCtD
Amoxapine—Pollakiuria—Doxorubicin—prostate cancer	0.000186	0.000487	CcSEcCtD
Amoxapine—Confusional state—Docetaxel—prostate cancer	0.000185	0.000485	CcSEcCtD
Amoxapine—Oedema—Docetaxel—prostate cancer	0.000184	0.000481	CcSEcCtD
Amoxapine—Weight increased—Doxorubicin—prostate cancer	0.000184	0.00048	CcSEcCtD
Amoxapine—Vision blurred—Prednisone—prostate cancer	0.000183	0.000479	CcSEcCtD
Amoxapine—Feeling abnormal—Etoposide—prostate cancer	0.000182	0.000477	CcSEcCtD
Amoxapine—Diarrhoea—Mitoxantrone—prostate cancer	0.000182	0.000476	CcSEcCtD
Amoxapine—Dry mouth—Capecitabine—prostate cancer	0.000182	0.000475	CcSEcCtD
Amoxapine—Vomiting—Estradiol—prostate cancer	0.000181	0.000474	CcSEcCtD
Amoxapine—Agranulocytosis—Epirubicin—prostate cancer	0.000181	0.000474	CcSEcCtD
Amoxapine—Gastrointestinal pain—Etoposide—prostate cancer	0.000181	0.000473	CcSEcCtD
Amoxapine—Shock—Docetaxel—prostate cancer	0.000181	0.000473	CcSEcCtD
Amoxapine—Thrombocytopenia—Docetaxel—prostate cancer	0.00018	0.000471	CcSEcCtD
Amoxapine—Rash—Estradiol—prostate cancer	0.00018	0.000471	CcSEcCtD
Amoxapine—Drowsiness—Doxorubicin—prostate cancer	0.00018	0.00047	CcSEcCtD
Amoxapine—Dermatitis—Estradiol—prostate cancer	0.00018	0.00047	CcSEcCtD
Amoxapine—Confusional state—Capecitabine—prostate cancer	0.000179	0.000469	CcSEcCtD
Amoxapine—Tachycardia—Docetaxel—prostate cancer	0.000179	0.000469	CcSEcCtD
Amoxapine—Headache—Estradiol—prostate cancer	0.000179	0.000467	CcSEcCtD
Amoxapine—Agitation—Prednisone—prostate cancer	0.000179	0.000467	CcSEcCtD
Amoxapine—Oedema—Capecitabine—prostate cancer	0.000178	0.000465	CcSEcCtD
Amoxapine—Urticaria—Etoposide—prostate cancer	0.000176	0.000459	CcSEcCtD
Amoxapine—Jaundice—Doxorubicin—prostate cancer	0.000175	0.000458	CcSEcCtD
Amoxapine—Stomatitis—Doxorubicin—prostate cancer	0.000175	0.000458	CcSEcCtD
Amoxapine—Anorexia—Docetaxel—prostate cancer	0.000175	0.000458	CcSEcCtD
Amoxapine—Shock—Capecitabine—prostate cancer	0.000175	0.000458	CcSEcCtD
Amoxapine—Body temperature increased—Etoposide—prostate cancer	0.000175	0.000457	CcSEcCtD
Amoxapine—Abdominal pain—Etoposide—prostate cancer	0.000175	0.000457	CcSEcCtD
Amoxapine—Hepatitis—Epirubicin—prostate cancer	0.000175	0.000456	CcSEcCtD
Amoxapine—Thrombocytopenia—Capecitabine—prostate cancer	0.000174	0.000456	CcSEcCtD
Amoxapine—Syncope—Prednisone—prostate cancer	0.000174	0.000455	CcSEcCtD
Amoxapine—Tachycardia—Capecitabine—prostate cancer	0.000174	0.000454	CcSEcCtD
Amoxapine—Hypoaesthesia—Epirubicin—prostate cancer	0.000174	0.000454	CcSEcCtD
Amoxapine—Chlordiazepoxide—CYP3A4—prostate cancer	0.000173	0.0184	CrCbGaD
Amoxapine—Hypotension—Docetaxel—prostate cancer	0.000172	0.000449	CcSEcCtD
Amoxapine—Loss of consciousness—Prednisone—prostate cancer	0.000171	0.000446	CcSEcCtD
Amoxapine—Anorexia—Capecitabine—prostate cancer	0.00017	0.000444	CcSEcCtD
Amoxapine—Nausea—Estradiol—prostate cancer	0.00017	0.000443	CcSEcCtD
Amoxapine—Vomiting—Mitoxantrone—prostate cancer	0.000169	0.000442	CcSEcCtD
Amoxapine—Convulsion—Prednisone—prostate cancer	0.000168	0.00044	CcSEcCtD
Amoxapine—Agranulocytosis—Doxorubicin—prostate cancer	0.000168	0.000439	CcSEcCtD
Amoxapine—Hypertension—Prednisone—prostate cancer	0.000168	0.000439	CcSEcCtD
Amoxapine—Rash—Mitoxantrone—prostate cancer	0.000168	0.000438	CcSEcCtD
Amoxapine—Dermatitis—Mitoxantrone—prostate cancer	0.000168	0.000438	CcSEcCtD
Amoxapine—Headache—Mitoxantrone—prostate cancer	0.000167	0.000436	CcSEcCtD
Amoxapine—Hypotension—Capecitabine—prostate cancer	0.000166	0.000435	CcSEcCtD
Amoxapine—Insomnia—Docetaxel—prostate cancer	0.000166	0.000435	CcSEcCtD
Amoxapine—Paraesthesia—Docetaxel—prostate cancer	0.000165	0.000432	CcSEcCtD
Amoxapine—Somnolence—Docetaxel—prostate cancer	0.000163	0.000427	CcSEcCtD
Amoxapine—Tinnitus—Epirubicin—prostate cancer	0.000163	0.000425	CcSEcCtD
Amoxapine—Dyspepsia—Docetaxel—prostate cancer	0.000162	0.000423	CcSEcCtD
Amoxapine—Temazepam—CYP2C19—prostate cancer	0.000162	0.0172	CrCbGaD
Amoxapine—Olanzapine—CYP3A4—prostate cancer	0.000162	0.0172	CrCbGaD
Amoxapine—Hepatitis—Doxorubicin—prostate cancer	0.000162	0.000422	CcSEcCtD
Amoxapine—Insomnia—Capecitabine—prostate cancer	0.000161	0.000421	CcSEcCtD
Amoxapine—Hypoaesthesia—Doxorubicin—prostate cancer	0.000161	0.00042	CcSEcCtD
Amoxapine—Paraesthesia—Capecitabine—prostate cancer	0.00016	0.000418	CcSEcCtD
Amoxapine—Decreased appetite—Docetaxel—prostate cancer	0.00016	0.000418	CcSEcCtD
Amoxapine—Asthenia—Etoposide—prostate cancer	0.000159	0.000415	CcSEcCtD
Amoxapine—Oedema—Prednisone—prostate cancer	0.000159	0.000415	CcSEcCtD
Amoxapine—Fatigue—Docetaxel—prostate cancer	0.000159	0.000414	CcSEcCtD
Amoxapine—Nausea—Mitoxantrone—prostate cancer	0.000158	0.000413	CcSEcCtD
Amoxapine—Constipation—Docetaxel—prostate cancer	0.000157	0.000411	CcSEcCtD
Amoxapine—Dyspepsia—Capecitabine—prostate cancer	0.000157	0.00041	CcSEcCtD
Amoxapine—Pruritus—Etoposide—prostate cancer	0.000157	0.000409	CcSEcCtD
Amoxapine—Shock—Prednisone—prostate cancer	0.000156	0.000408	CcSEcCtD
Amoxapine—Tachycardia—Prednisone—prostate cancer	0.000155	0.000405	CcSEcCtD
Amoxapine—Decreased appetite—Capecitabine—prostate cancer	0.000155	0.000405	CcSEcCtD
Amoxapine—Quetiapine—CYP2C19—prostate cancer	0.000154	0.0164	CrCbGaD
Amoxapine—Alopecia—Epirubicin—prostate cancer	0.000154	0.000403	CcSEcCtD
Amoxapine—Fatigue—Capecitabine—prostate cancer	0.000153	0.000401	CcSEcCtD
Amoxapine—Constipation—Capecitabine—prostate cancer	0.000152	0.000398	CcSEcCtD
Amoxapine—Feeling abnormal—Docetaxel—prostate cancer	0.000152	0.000396	CcSEcCtD
Amoxapine—Diarrhoea—Etoposide—prostate cancer	0.000151	0.000396	CcSEcCtD
Amoxapine—Anorexia—Prednisone—prostate cancer	0.000151	0.000395	CcSEcCtD
Amoxapine—Tinnitus—Doxorubicin—prostate cancer	0.000151	0.000394	CcSEcCtD
Amoxapine—Gastrointestinal pain—Docetaxel—prostate cancer	0.00015	0.000393	CcSEcCtD
Amoxapine—Flatulence—Epirubicin—prostate cancer	0.00015	0.000391	CcSEcCtD
Amoxapine—Tension—Epirubicin—prostate cancer	0.000149	0.00039	CcSEcCtD
Amoxapine—Dysgeusia—Epirubicin—prostate cancer	0.000149	0.000389	CcSEcCtD
Amoxapine—Nervousness—Epirubicin—prostate cancer	0.000148	0.000386	CcSEcCtD
Amoxapine—Feeling abnormal—Capecitabine—prostate cancer	0.000147	0.000383	CcSEcCtD
Amoxapine—Dizziness—Etoposide—prostate cancer	0.000146	0.000382	CcSEcCtD
Amoxapine—Gastrointestinal pain—Capecitabine—prostate cancer	0.000146	0.000381	CcSEcCtD
Amoxapine—Abdominal pain—Docetaxel—prostate cancer	0.000145	0.00038	CcSEcCtD
Amoxapine—Body temperature increased—Docetaxel—prostate cancer	0.000145	0.00038	CcSEcCtD
Amoxapine—Insomnia—Prednisone—prostate cancer	0.000143	0.000375	CcSEcCtD
Amoxapine—Vision blurred—Epirubicin—prostate cancer	0.000143	0.000374	CcSEcCtD
Amoxapine—Alopecia—Doxorubicin—prostate cancer	0.000143	0.000373	CcSEcCtD
Amoxapine—Paraesthesia—Prednisone—prostate cancer	0.000142	0.000372	CcSEcCtD
Amoxapine—Urticaria—Capecitabine—prostate cancer	0.000141	0.00037	CcSEcCtD
Amoxapine—Body temperature increased—Capecitabine—prostate cancer	0.000141	0.000368	CcSEcCtD
Amoxapine—Abdominal pain—Capecitabine—prostate cancer	0.000141	0.000368	CcSEcCtD
Amoxapine—Vomiting—Etoposide—prostate cancer	0.000141	0.000368	CcSEcCtD
Amoxapine—Agitation—Epirubicin—prostate cancer	0.00014	0.000365	CcSEcCtD
Amoxapine—Dyspepsia—Prednisone—prostate cancer	0.00014	0.000365	CcSEcCtD
Amoxapine—Rash—Etoposide—prostate cancer	0.000139	0.000365	CcSEcCtD
Amoxapine—Dermatitis—Etoposide—prostate cancer	0.000139	0.000364	CcSEcCtD
Amoxapine—Headache—Etoposide—prostate cancer	0.000139	0.000362	CcSEcCtD
Amoxapine—Flatulence—Doxorubicin—prostate cancer	0.000139	0.000362	CcSEcCtD
Amoxapine—Tension—Doxorubicin—prostate cancer	0.000138	0.000361	CcSEcCtD
Amoxapine—Decreased appetite—Prednisone—prostate cancer	0.000138	0.00036	CcSEcCtD
Amoxapine—Dysgeusia—Doxorubicin—prostate cancer	0.000138	0.00036	CcSEcCtD
Amoxapine—Fatigue—Prednisone—prostate cancer	0.000137	0.000357	CcSEcCtD
Amoxapine—Nervousness—Doxorubicin—prostate cancer	0.000137	0.000357	CcSEcCtD
Amoxapine—Syncope—Epirubicin—prostate cancer	0.000136	0.000356	CcSEcCtD
Amoxapine—Leukopenia—Epirubicin—prostate cancer	0.000136	0.000356	CcSEcCtD
Amoxapine—Diazepam—CYP2E1—prostate cancer	0.000136	0.0144	CrCbGaD
Amoxapine—Constipation—Prednisone—prostate cancer	0.000136	0.000354	CcSEcCtD
Amoxapine—Diazepam—CYP2C19—prostate cancer	0.000134	0.0143	CrCbGaD
Amoxapine—Palpitations—Epirubicin—prostate cancer	0.000134	0.000351	CcSEcCtD
Amoxapine—Clozapine—CYP2E1—prostate cancer	0.000134	0.0143	CrCbGaD
Amoxapine—Loss of consciousness—Epirubicin—prostate cancer	0.000134	0.000349	CcSEcCtD
Amoxapine—Clozapine—CYP2C19—prostate cancer	0.000133	0.0141	CrCbGaD
Amoxapine—Vision blurred—Doxorubicin—prostate cancer	0.000132	0.000346	CcSEcCtD
Amoxapine—Clozapine—CYP1A1—prostate cancer	0.000132	0.0141	CrCbGaD
Amoxapine—Asthenia—Docetaxel—prostate cancer	0.000132	0.000345	CcSEcCtD
Amoxapine—Convulsion—Epirubicin—prostate cancer	0.000132	0.000344	CcSEcCtD
Amoxapine—Nausea—Etoposide—prostate cancer	0.000131	0.000344	CcSEcCtD
Amoxapine—Hypertension—Epirubicin—prostate cancer	0.000131	0.000343	CcSEcCtD
Amoxapine—Feeling abnormal—Prednisone—prostate cancer	0.000131	0.000342	CcSEcCtD
Amoxapine—Pruritus—Docetaxel—prostate cancer	0.00013	0.00034	CcSEcCtD
Amoxapine—Gastrointestinal pain—Prednisone—prostate cancer	0.00013	0.000339	CcSEcCtD
Amoxapine—Agitation—Doxorubicin—prostate cancer	0.000129	0.000338	CcSEcCtD
Amoxapine—Asthenia—Capecitabine—prostate cancer	0.000128	0.000334	CcSEcCtD
Amoxapine—Dry mouth—Epirubicin—prostate cancer	0.000127	0.000331	CcSEcCtD
Amoxapine—Syncope—Doxorubicin—prostate cancer	0.000126	0.00033	CcSEcCtD
Amoxapine—Urticaria—Prednisone—prostate cancer	0.000126	0.000329	CcSEcCtD
Amoxapine—Pruritus—Capecitabine—prostate cancer	0.000126	0.000329	CcSEcCtD
Amoxapine—Leukopenia—Doxorubicin—prostate cancer	0.000126	0.000329	CcSEcCtD
Amoxapine—Diarrhoea—Docetaxel—prostate cancer	0.000126	0.000329	CcSEcCtD
Amoxapine—Estazolam—CYP3A4—prostate cancer	0.000125	0.0133	CrCbGaD
Amoxapine—Body temperature increased—Prednisone—prostate cancer	0.000125	0.000328	CcSEcCtD
Amoxapine—Abdominal pain—Prednisone—prostate cancer	0.000125	0.000328	CcSEcCtD
Amoxapine—Confusional state—Epirubicin—prostate cancer	0.000125	0.000327	CcSEcCtD
Amoxapine—Palpitations—Doxorubicin—prostate cancer	0.000124	0.000325	CcSEcCtD
Amoxapine—Oedema—Epirubicin—prostate cancer	0.000124	0.000324	CcSEcCtD
Amoxapine—Loss of consciousness—Doxorubicin—prostate cancer	0.000124	0.000323	CcSEcCtD
Amoxapine—Shock—Epirubicin—prostate cancer	0.000122	0.000319	CcSEcCtD
Amoxapine—Convulsion—Doxorubicin—prostate cancer	0.000122	0.000318	CcSEcCtD
Amoxapine—Diarrhoea—Capecitabine—prostate cancer	0.000122	0.000318	CcSEcCtD
Amoxapine—Dizziness—Docetaxel—prostate cancer	0.000122	0.000318	CcSEcCtD
Amoxapine—Thrombocytopenia—Epirubicin—prostate cancer	0.000121	0.000317	CcSEcCtD
Amoxapine—Hypertension—Doxorubicin—prostate cancer	0.000121	0.000317	CcSEcCtD
Amoxapine—Tachycardia—Epirubicin—prostate cancer	0.000121	0.000316	CcSEcCtD
Amoxapine—Anorexia—Epirubicin—prostate cancer	0.000118	0.000309	CcSEcCtD
Amoxapine—Dizziness—Capecitabine—prostate cancer	0.000118	0.000308	CcSEcCtD
Amoxapine—Dry mouth—Doxorubicin—prostate cancer	0.000117	0.000306	CcSEcCtD
Amoxapine—Vomiting—Docetaxel—prostate cancer	0.000117	0.000306	CcSEcCtD
Amoxapine—Rash—Docetaxel—prostate cancer	0.000116	0.000303	CcSEcCtD
Amoxapine—Hypotension—Epirubicin—prostate cancer	0.000116	0.000303	CcSEcCtD
Amoxapine—Dermatitis—Docetaxel—prostate cancer	0.000116	0.000303	CcSEcCtD
Amoxapine—Confusional state—Doxorubicin—prostate cancer	0.000116	0.000302	CcSEcCtD
Amoxapine—Prazepam—CYP3A4—prostate cancer	0.000115	0.0123	CrCbGaD
Amoxapine—Headache—Docetaxel—prostate cancer	0.000115	0.000301	CcSEcCtD
Amoxapine—Oedema—Doxorubicin—prostate cancer	0.000115	0.0003	CcSEcCtD
Amoxapine—Asthenia—Prednisone—prostate cancer	0.000114	0.000297	CcSEcCtD
Amoxapine—Vomiting—Capecitabine—prostate cancer	0.000113	0.000296	CcSEcCtD
Amoxapine—Shock—Doxorubicin—prostate cancer	0.000113	0.000295	CcSEcCtD
Amoxapine—Thrombocytopenia—Doxorubicin—prostate cancer	0.000112	0.000294	CcSEcCtD
Amoxapine—Rash—Capecitabine—prostate cancer	0.000112	0.000293	CcSEcCtD
Amoxapine—Pruritus—Prednisone—prostate cancer	0.000112	0.000293	CcSEcCtD
Amoxapine—Insomnia—Epirubicin—prostate cancer	0.000112	0.000293	CcSEcCtD
Amoxapine—Dermatitis—Capecitabine—prostate cancer	0.000112	0.000293	CcSEcCtD
Amoxapine—Tachycardia—Doxorubicin—prostate cancer	0.000112	0.000293	CcSEcCtD
Amoxapine—Headache—Capecitabine—prostate cancer	0.000112	0.000292	CcSEcCtD
Amoxapine—Paraesthesia—Epirubicin—prostate cancer	0.000111	0.000291	CcSEcCtD
Amoxapine—Somnolence—Epirubicin—prostate cancer	0.00011	0.000288	CcSEcCtD
Amoxapine—Anorexia—Doxorubicin—prostate cancer	0.000109	0.000286	CcSEcCtD
Amoxapine—Nausea—Docetaxel—prostate cancer	0.000109	0.000286	CcSEcCtD
Amoxapine—Dyspepsia—Epirubicin—prostate cancer	0.000109	0.000285	CcSEcCtD
Amoxapine—Diarrhoea—Prednisone—prostate cancer	0.000108	0.000284	CcSEcCtD
Amoxapine—Decreased appetite—Epirubicin—prostate cancer	0.000108	0.000282	CcSEcCtD
Amoxapine—Hypotension—Doxorubicin—prostate cancer	0.000107	0.00028	CcSEcCtD
Amoxapine—Fatigue—Epirubicin—prostate cancer	0.000107	0.00028	CcSEcCtD
Amoxapine—Constipation—Epirubicin—prostate cancer	0.000106	0.000277	CcSEcCtD
Amoxapine—Nausea—Capecitabine—prostate cancer	0.000106	0.000276	CcSEcCtD
Amoxapine—Dizziness—Prednisone—prostate cancer	0.000105	0.000274	CcSEcCtD
Amoxapine—Oxazepam—CYP3A4—prostate cancer	0.000104	0.0111	CrCbGaD
Amoxapine—Insomnia—Doxorubicin—prostate cancer	0.000104	0.000271	CcSEcCtD
Amoxapine—Paraesthesia—Doxorubicin—prostate cancer	0.000103	0.000269	CcSEcCtD
Amoxapine—Temazepam—CYP3A4—prostate cancer	0.000103	0.0109	CrCbGaD
Amoxapine—Feeling abnormal—Epirubicin—prostate cancer	0.000102	0.000267	CcSEcCtD
Amoxapine—Somnolence—Doxorubicin—prostate cancer	0.000102	0.000267	CcSEcCtD
Amoxapine—Gastrointestinal pain—Epirubicin—prostate cancer	0.000101	0.000265	CcSEcCtD
Amoxapine—Dyspepsia—Doxorubicin—prostate cancer	0.000101	0.000264	CcSEcCtD
Amoxapine—Vomiting—Prednisone—prostate cancer	0.000101	0.000264	CcSEcCtD
Amoxapine—Rash—Prednisone—prostate cancer	0.0001	0.000261	CcSEcCtD
Amoxapine—Dermatitis—Prednisone—prostate cancer	9.99e-05	0.000261	CcSEcCtD
Amoxapine—Decreased appetite—Doxorubicin—prostate cancer	9.97e-05	0.000261	CcSEcCtD
Amoxapine—Headache—Prednisone—prostate cancer	9.93e-05	0.00026	CcSEcCtD
Amoxapine—Fatigue—Doxorubicin—prostate cancer	9.89e-05	0.000259	CcSEcCtD
Amoxapine—Urticaria—Epirubicin—prostate cancer	9.85e-05	0.000258	CcSEcCtD
Amoxapine—Constipation—Doxorubicin—prostate cancer	9.81e-05	0.000257	CcSEcCtD
Amoxapine—Quetiapine—CYP3A4—prostate cancer	9.81e-05	0.0104	CrCbGaD
Amoxapine—Abdominal pain—Epirubicin—prostate cancer	9.8e-05	0.000256	CcSEcCtD
Amoxapine—Body temperature increased—Epirubicin—prostate cancer	9.8e-05	0.000256	CcSEcCtD
Amoxapine—Feeling abnormal—Doxorubicin—prostate cancer	9.46e-05	0.000247	CcSEcCtD
Amoxapine—Nausea—Prednisone—prostate cancer	9.42e-05	0.000246	CcSEcCtD
Amoxapine—Gastrointestinal pain—Doxorubicin—prostate cancer	9.38e-05	0.000245	CcSEcCtD
Amoxapine—Urticaria—Doxorubicin—prostate cancer	9.12e-05	0.000238	CcSEcCtD
Amoxapine—Body temperature increased—Doxorubicin—prostate cancer	9.07e-05	0.000237	CcSEcCtD
Amoxapine—Abdominal pain—Doxorubicin—prostate cancer	9.07e-05	0.000237	CcSEcCtD
Amoxapine—Asthenia—Epirubicin—prostate cancer	8.9e-05	0.000233	CcSEcCtD
Amoxapine—Pruritus—Epirubicin—prostate cancer	8.77e-05	0.000229	CcSEcCtD
Amoxapine—Diazepam—CYP3A4—prostate cancer	8.55e-05	0.00909	CrCbGaD
Amoxapine—Diarrhoea—Epirubicin—prostate cancer	8.48e-05	0.000222	CcSEcCtD
Amoxapine—Clozapine—CYP3A4—prostate cancer	8.44e-05	0.00898	CrCbGaD
Amoxapine—Asthenia—Doxorubicin—prostate cancer	8.23e-05	0.000215	CcSEcCtD
Amoxapine—Dizziness—Epirubicin—prostate cancer	8.2e-05	0.000214	CcSEcCtD
Amoxapine—Pruritus—Doxorubicin—prostate cancer	8.12e-05	0.000212	CcSEcCtD
Amoxapine—Vomiting—Epirubicin—prostate cancer	7.88e-05	0.000206	CcSEcCtD
Amoxapine—Diarrhoea—Doxorubicin—prostate cancer	7.85e-05	0.000205	CcSEcCtD
Amoxapine—Rash—Epirubicin—prostate cancer	7.82e-05	0.000204	CcSEcCtD
Amoxapine—Dermatitis—Epirubicin—prostate cancer	7.81e-05	0.000204	CcSEcCtD
Amoxapine—Headache—Epirubicin—prostate cancer	7.77e-05	0.000203	CcSEcCtD
Amoxapine—Dizziness—Doxorubicin—prostate cancer	7.59e-05	0.000198	CcSEcCtD
Amoxapine—Nausea—Epirubicin—prostate cancer	7.37e-05	0.000193	CcSEcCtD
Amoxapine—Vomiting—Doxorubicin—prostate cancer	7.3e-05	0.000191	CcSEcCtD
Amoxapine—Rash—Doxorubicin—prostate cancer	7.23e-05	0.000189	CcSEcCtD
Amoxapine—Dermatitis—Doxorubicin—prostate cancer	7.23e-05	0.000189	CcSEcCtD
Amoxapine—Headache—Doxorubicin—prostate cancer	7.19e-05	0.000188	CcSEcCtD
Amoxapine—Nausea—Doxorubicin—prostate cancer	6.82e-05	0.000178	CcSEcCtD
Amoxapine—DRD2—Signaling Pathways—PIK3CB—prostate cancer	4.32e-06	1.87e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CAV1—prostate cancer	4.32e-06	1.87e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ERBB2—prostate cancer	4.31e-06	1.87e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ERBB2—prostate cancer	4.3e-06	1.86e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	4.3e-06	1.86e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—KRAS—prostate cancer	4.29e-06	1.86e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ERBB2—prostate cancer	4.29e-06	1.86e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MDM2—prostate cancer	4.28e-06	1.86e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—prostate cancer	4.28e-06	1.85e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—prostate cancer	4.26e-06	1.85e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	4.26e-06	1.85e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—prostate cancer	4.26e-06	1.85e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PTEN—prostate cancer	4.25e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CB—prostate cancer	4.25e-06	1.84e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—FGF2—prostate cancer	4.25e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	4.24e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CDKN1A—prostate cancer	4.24e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PTEN—prostate cancer	4.23e-06	1.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	4.23e-06	1.83e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	4.22e-06	1.83e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—KRAS—prostate cancer	4.22e-06	1.83e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOS3—prostate cancer	4.19e-06	1.82e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	4.16e-06	1.8e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL8—prostate cancer	4.15e-06	1.8e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—prostate cancer	4.15e-06	1.8e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—prostate cancer	4.13e-06	1.79e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MYC—prostate cancer	4.11e-06	1.78e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFB1—prostate cancer	4.1e-06	1.78e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—prostate cancer	4.09e-06	1.77e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—prostate cancer	4.08e-06	1.77e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—JAK2—prostate cancer	4.07e-06	1.77e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—prostate cancer	4.06e-06	1.76e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EP300—prostate cancer	4.06e-06	1.76e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1B—prostate cancer	4.06e-06	1.76e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—prostate cancer	4.06e-06	1.76e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PIK3CA—prostate cancer	4.05e-06	1.76e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PIK3CA—prostate cancer	4.05e-06	1.76e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFB1—prostate cancer	4.05e-06	1.75e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EP300—prostate cancer	4.04e-06	1.75e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KRAS—prostate cancer	4.03e-06	1.75e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—prostate cancer	4.02e-06	1.74e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	4.01e-06	1.74e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	4e-06	1.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTEN—prostate cancer	4e-06	1.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	3.99e-06	1.73e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1B—prostate cancer	3.99e-06	1.73e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	3.98e-06	1.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MDM2—prostate cancer	3.98e-06	1.72e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—prostate cancer	3.97e-06	1.72e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	3.97e-06	1.72e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—prostate cancer	3.97e-06	1.72e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—prostate cancer	3.97e-06	1.72e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—prostate cancer	3.95e-06	1.71e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	3.95e-06	1.71e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SRC—prostate cancer	3.94e-06	1.71e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	3.94e-06	1.71e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	3.94e-06	1.71e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.93e-06	1.71e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	3.93e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SRC—prostate cancer	3.92e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—prostate cancer	3.92e-06	1.7e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	3.92e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—prostate cancer	3.92e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—prostate cancer	3.91e-06	1.7e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	3.91e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—prostate cancer	3.91e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—prostate cancer	3.9e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—prostate cancer	3.9e-06	1.69e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—prostate cancer	3.89e-06	1.69e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—prostate cancer	3.89e-06	1.68e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—prostate cancer	3.88e-06	1.68e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—prostate cancer	3.88e-06	1.68e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PIK3CA—prostate cancer	3.88e-06	1.68e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCND1—prostate cancer	3.87e-06	1.68e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	3.87e-06	1.68e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	3.87e-06	1.68e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—prostate cancer	3.86e-06	1.68e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—prostate cancer	3.84e-06	1.67e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	3.83e-06	1.66e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	3.83e-06	1.66e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—prostate cancer	3.82e-06	1.66e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—prostate cancer	3.82e-06	1.66e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—EP300—prostate cancer	3.81e-06	1.65e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—prostate cancer	3.81e-06	1.65e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCND1—prostate cancer	3.81e-06	1.65e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	3.8e-06	1.65e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—prostate cancer	3.8e-06	1.65e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCND1—prostate cancer	3.8e-06	1.65e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KRAS—prostate cancer	3.8e-06	1.65e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCND1—prostate cancer	3.79e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—prostate cancer	3.78e-06	1.64e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	3.77e-06	1.63e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	3.76e-06	1.63e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—prostate cancer	3.76e-06	1.63e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	3.75e-06	1.63e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—prostate cancer	3.75e-06	1.63e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KRAS—prostate cancer	3.75e-06	1.62e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	3.74e-06	1.62e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PTEN—prostate cancer	3.73e-06	1.62e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	3.73e-06	1.62e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—INS—prostate cancer	3.72e-06	1.61e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	3.72e-06	1.61e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	3.7e-06	1.6e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—prostate cancer	3.7e-06	1.6e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	3.69e-06	1.6e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—prostate cancer	3.69e-06	1.6e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	3.68e-06	1.6e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—prostate cancer	3.68e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	3.67e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PTEN—prostate cancer	3.67e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PTEN—prostate cancer	3.67e-06	1.59e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	3.66e-06	1.59e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PTEN—prostate cancer	3.65e-06	1.58e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CREBBP—prostate cancer	3.65e-06	1.58e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—prostate cancer	3.64e-06	1.58e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	3.63e-06	1.57e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	3.62e-06	1.57e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	3.61e-06	1.56e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	3.6e-06	1.56e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	3.59e-06	1.56e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—prostate cancer	3.59e-06	1.56e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—prostate cancer	3.59e-06	1.55e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	3.58e-06	1.55e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—prostate cancer	3.58e-06	1.55e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—prostate cancer	3.58e-06	1.55e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	3.57e-06	1.55e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EP300—prostate cancer	3.56e-06	1.54e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	3.56e-06	1.54e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—prostate cancer	3.55e-06	1.54e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	3.53e-06	1.53e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—prostate cancer	3.53e-06	1.53e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	3.53e-06	1.53e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—prostate cancer	3.52e-06	1.52e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	3.51e-06	1.52e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	3.51e-06	1.52e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EP300—prostate cancer	3.5e-06	1.52e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EP300—prostate cancer	3.5e-06	1.52e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	3.49e-06	1.51e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—prostate cancer	3.49e-06	1.51e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EP300—prostate cancer	3.49e-06	1.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	3.46e-06	1.5e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SRC—prostate cancer	3.46e-06	1.5e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CD—prostate cancer	3.46e-06	1.5e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—prostate cancer	3.46e-06	1.5e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PIK3CA—prostate cancer	3.44e-06	1.49e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—prostate cancer	3.44e-06	1.49e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—prostate cancer	3.43e-06	1.49e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EP300—prostate cancer	3.43e-06	1.49e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	3.43e-06	1.49e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SRC—prostate cancer	3.41e-06	1.48e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SRC—prostate cancer	3.4e-06	1.47e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SRC—prostate cancer	3.39e-06	1.47e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—prostate cancer	3.38e-06	1.46e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—prostate cancer	3.37e-06	1.46e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	3.36e-06	1.46e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	3.35e-06	1.45e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	3.34e-06	1.45e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—prostate cancer	3.34e-06	1.45e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SRC—prostate cancer	3.34e-06	1.45e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—prostate cancer	3.33e-06	1.44e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	3.32e-06	1.44e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—prostate cancer	3.31e-06	1.44e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—prostate cancer	3.31e-06	1.44e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—prostate cancer	3.31e-06	1.43e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	3.3e-06	1.43e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—prostate cancer	3.29e-06	1.42e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—prostate cancer	3.28e-06	1.42e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—prostate cancer	3.28e-06	1.42e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—prostate cancer	3.27e-06	1.42e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NOS3—prostate cancer	3.27e-06	1.42e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KRAS—prostate cancer	3.27e-06	1.42e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	3.26e-06	1.41e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	3.25e-06	1.41e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KRAS—prostate cancer	3.25e-06	1.41e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—prostate cancer	3.22e-06	1.39e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	3.22e-06	1.39e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EP300—prostate cancer	3.19e-06	1.38e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—prostate cancer	3.17e-06	1.37e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—prostate cancer	3.1e-06	1.35e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SRC—prostate cancer	3.1e-06	1.34e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFB1—prostate cancer	3.1e-06	1.34e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—prostate cancer	3.09e-06	1.34e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—prostate cancer	3.05e-06	1.32e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—prostate cancer	3.05e-06	1.32e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—prostate cancer	3.05e-06	1.32e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	3.05e-06	1.32e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFB1—prostate cancer	3.04e-06	1.32e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—prostate cancer	3.04e-06	1.32e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—prostate cancer	3.04e-06	1.32e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	3.03e-06	1.31e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—prostate cancer	3.02e-06	1.31e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	3.02e-06	1.31e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CB—prostate cancer	3.01e-06	1.31e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	3e-06	1.3e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—prostate cancer	2.99e-06	1.3e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	2.99e-06	1.3e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—prostate cancer	2.99e-06	1.29e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—prostate cancer	2.99e-06	1.29e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	2.99e-06	1.29e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	2.98e-06	1.29e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—prostate cancer	2.98e-06	1.29e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—prostate cancer	2.97e-06	1.29e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	2.92e-06	1.27e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—prostate cancer	2.9e-06	1.26e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—prostate cancer	2.89e-06	1.25e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KRAS—prostate cancer	2.87e-06	1.24e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—prostate cancer	2.85e-06	1.24e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KRAS—prostate cancer	2.82e-06	1.22e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PIK3CA—prostate cancer	2.82e-06	1.22e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KRAS—prostate cancer	2.82e-06	1.22e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—prostate cancer	2.81e-06	1.22e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KRAS—prostate cancer	2.81e-06	1.22e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—prostate cancer	2.78e-06	1.2e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	2.77e-06	1.2e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	2.76e-06	1.2e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	2.72e-06	1.18e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—prostate cancer	2.66e-06	1.15e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—prostate cancer	2.64e-06	1.15e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	2.63e-06	1.14e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTEN—prostate cancer	2.61e-06	1.13e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	2.59e-06	1.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	2.59e-06	1.12e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	2.58e-06	1.12e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	2.57e-06	1.11e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—prostate cancer	2.55e-06	1.1e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	2.54e-06	1.1e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—prostate cancer	2.51e-06	1.09e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—prostate cancer	2.5e-06	1.08e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—prostate cancer	2.49e-06	1.08e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—EP300—prostate cancer	2.48e-06	1.08e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—prostate cancer	2.46e-06	1.06e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—prostate cancer	2.45e-06	1.06e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—prostate cancer	2.44e-06	1.06e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	2.36e-06	1.02e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—prostate cancer	2.33e-06	1.01e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—prostate cancer	2.3e-06	9.99e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—prostate cancer	2.3e-06	9.95e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—prostate cancer	2.29e-06	9.93e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—prostate cancer	2.28e-06	9.9e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—prostate cancer	2.28e-06	9.89e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—prostate cancer	2.25e-06	9.74e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—prostate cancer	2.15e-06	9.33e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—prostate cancer	2.12e-06	9.18e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—prostate cancer	2.11e-06	9.16e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—prostate cancer	2.11e-06	9.13e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—prostate cancer	2.09e-06	9.05e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	2.07e-06	8.99e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	1.93e-06	8.35e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.84e-06	7.97e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—prostate cancer	1.5e-06	6.51e-06	CbGpPWpGaD
